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FATHER’S GIFT TO VITE
LAB IS PERSONAL
BY SACHA ADORNO

SOON AFTER GALYA CHAN WAS BORN, HER LIVER BEGAN
GROWING AT AN ALARMING RATE—SO QUICKLY THAT BY THE
TIME SHE TURNED ONE, IT WAS THE SIZE OF A 13-YEAR-OLD’S.
WITH DOCTORS UNABLE TO IDENTIFY THE CAUSE, GALYA SPENT
THE BETTER PART OF HER FIRST YEAR IN AN INTENSIVE CARE UNIT.
After 12 frustrating and frightening months,
the Chans finally received a diagnosis of
Niemann-Pick type C disease (NPC), a
rare, incurable childhood disease caused by
the accumulation of excessive amounts of
cholesterol and glycosphingolipids in the
brain and other organs. Without FDAapproved treatments, and with only drugs to
manage symptoms, young people with the
degenerative condition often die before the
age of 20.
“NPC is so rare that in all of Los Angeles,
where we live, there are only four known
cases,” says Brian Chan, Galya’s dad. “I’ve
spent hundreds of hours researching it and
talking to other families. As most NPC
families do, I eventually ran into Dr. Vite at
Penn Vet.”
Dr. Charles H. Vite, Associate Professor
of Veterinary Neurology, is part of a
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collaborative community of researchers
around the world who are tackling NPC.
Recently, he was the lead author of a
study published in Science Translational
Medicine that finds cats with NPC show vast
improvement when treated with a compound
called cyclodextrin. While NPC, which
naturally occurs in cats and follows the same
progression as it does in children, typically
results in inexorable neurological decline,
administering cyclodextrin into the fluid
around the cats’ brains largely halted the
disease’s progression. This study paved the
way for the FDA to approve a Phase I clinical
trial in children. A Phase 2/3 trial began this
past fall.
For the Chans and other parents of
children with NPC, breakthroughs like
this offer hope. Determined to maintain
forward momentum, they have become
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active participants in NPC research, getting
to know scientists and raising funds to keep
studies moving.
Brian Chan is the founder of Liferay, Inc.,
an open source software company, and part
of SOAR-NPC (Support of Accelerated
Research for NPC), a scientist-clinicianpatient advocate collaborative. After visiting
Dr. Vite’s lab with a group of parents, Chan
asked what was needed to accelerate research.
“A new microscope was high on the list,”
Chan says.
Without hesitation, he offered to support
the purchase of a state-of-the-art microscope
that will greatly enhance Penn Vet’s ability
to study NPC. Features like whole-slide
scanning and 3-D reconstruction; digital
archiving and sharing functions; highresolution and live-cell, real-time imaging;
and multiplexing capabilities will enable a

better understanding of NPC’s process. As
a result, researchers can spend more time
analyzing data and less time imaging it.
“We are grateful to Brian for this gift, and
thankful for all of the determined, amazing
families behind NPC research,” says Vite.
“They alone have helped fund 20 percent of
our lab. We have essential NIH funding—we
couldn’t get by without it—but what really
pushes things along is the involvement of the
parents.”
Regarding this unique partnership between
families and researchers, Chan adds, “Doctors
and scientists take an academic approach. For
parents, it’s personal. If you add a personal
touch to scientific rigor, the results are
better than if you have just academic data or
parental passion. When you combine both…
bam, things happen.”

“We are grateful to
Brian for this gift,

and thankful for all
of the determined,
amazing families

behind NPC research.”
—Dr. Charles H. Vite
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